2Q Pharma Results Preview: Pfizer, Allergan, Teva, Merck KGaA & Shire
Executive Summary
Pfizer will anchor the final week of major biopharma earnings calls, facing the same question as every firm with massive stockpiles of cash: When are you going to spend that money on a transformative M&A deal?